Effect of Dexamethason on Postimplantation Syndrome After EVAR

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 158 participants.

Also called NCT06044480

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 158 participants (planned count) (from the registry)
Sponsor
Centro Hospitalar de Lisboa Central (from the registry)
Registry
  • NCT NCT06044480
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06044480. Randomized; triple masking; primary purpose prevention. Start 2023-11-01 (anticipated); primary completion 2025-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Dexamethason on Postimplantation Syndrome After EVAR
Acronym
DEPOS
Condition
Aneurysm Abdominal
Condition
Endovascular Aneurysm Repair
Condition
Postimplantation Syndrome
Condition
Dexamethasone
Intervention (Drug)
Dexamethasone
Intervention (Other)
Placebo
Lead sponsor
Centro Hospitalar de Lisboa Central (class: other)

Record details

Record id
cardio:ct-nct06044480
Content hash
65edc69eebea976b21e4a0c3c48827a3fd1df47037c61aa10d44ad85afabccfa